Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000869754 | SCV001011209 | likely benign | Tuberous sclerosis 2 | 2023-12-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001022929 | SCV001184729 | likely benign | Hereditary cancer-predisposing syndrome | 2019-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001556902 | SCV001778567 | likely benign | not provided | 2020-11-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 9302281) |
Genome- |
RCV000869754 | SCV002039513 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001556902 | SCV004184511 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |
All of Us Research Program, |
RCV004003051 | SCV004818147 | likely benign | Tuberous sclerosis syndrome | 2023-11-30 | criteria provided, single submitter | clinical testing |